Masahiro Kobayashi
- Hepatology top 0.02%
- Hepatitis C virus research 256
- Hepatocellular Carcinoma Treatment and Prognosis 93
- Liver Disease and Transplantation 29
- Liver Diseases and Immunity 22
- Epidemiology top 0.05%
- Liver Disease Diagnosis and Treatment 261
- Hepatitis B Virus Studies 189
- Cancer Research top 1%
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment 40
- Oncology top 1%
-
- Systemic Lupus Erythematosus Research 27
- Co-authors
- Hiromitsu KumadaYoshiyuki SuzukiYasuji AraseFumitaka SuzukiSatoshi SaitohNorio AkutaTetsuya HosakaHitomi Sezaki
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (7 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Masahiro Kobayashi
452 papers receiving 14.8k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Hepatology 11.3k
- Epidemiology 9.8k
- Cancer Research 1.2k
- Infectious Diseases 1.2k
- Oncology 1.7k
Countries citing papers authored by Masahiro Kobayashi
This map shows the geographic impact of Masahiro Kobayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Kobayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Kobayashi more than expected).
Fields of papers citing papers by Masahiro Kobayashi
This network shows the impact of papers produced by Masahiro Kobayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Kobayashi. The network helps show where Masahiro Kobayashi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Masahiro Kobayashi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2022 | 1 | |
| 4 | 2022 | 0 | |
| 5 | 2022 | 1 | |
| 6 | 2021 | 10 | |
| 7 | 2019 | 12 | |
| 8 | 2019 | 11 | |
| 9 | 2017 | 55 | |
| 10 | Correlation of Histopathological Features andGenetic Variations with Prognosis of JapanesePatients with Nonalcoholic Fatty Liver Disease | 2016 | 1 |
| 11 | 2015 | 92 | |
| 12 | Effect of Drug on Physical Characteristics of Oral Methylcellulose/Alginate Formulation | 2014 | 1 |
| 13 | 2011 | 312 | |
| 14 | [Transcatheter arterial chemotherapy with miriplatin for patients with hepatocellular carcinoma and chronic renal failure]. | 2011 | 2 |
| 15 | Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinomabreakdown → | 2009 | 872 |
| 16 | 2008 | 3 | |
| 17 | 2006 | 25 | |
| 18 | 2004 | 8 | |
| 19 | 1992 | 0 | |
| 20 | 1991 | 0 |
About Masahiro Kobayashi
Masahiro Kobayashi is a scholar working on Hepatology, Epidemiology and Infectious Diseases, having authored 473 papers that have together received 15.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (261 papers), Hepatitis C virus research (256 papers), Hepatitis B Virus Studies (189 papers), Hepatocellular Carcinoma Treatment and Prognosis (93 papers), HIV/AIDS drug development and treatment (40 papers), Liver Disease and Transplantation (29 papers), Systemic Lupus Erythematosus Research (27 papers) and Liver Diseases and Immunity (22 papers). The work is most often cited by research in Hepatology (11.3k citations), Epidemiology (9.8k citations) and Cancer Research (1.2k citations). Masahiro Kobayashi has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Hiromitsu Kumada, Yoshiyuki Suzuki, Yasuji Arase, Fumitaka Suzuki, Satoshi Saitoh, Norio Akuta, Tetsuya Hosaka, Hitomi Sezaki, Kenji Ikeda and Yusuke Kawamura. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.